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Purpose
The purpose of this study was to evaluate feasibility and
obtain preliminary efficacy estimates comparing cranio-
sacral therapy (CST) with an attention-control condition
for the adjunctive treatment of migraine.
Methods
Individuals with moderate to severe migraine were
recruited from specialty clinics, family practices, and the
university community. After confirmatory clinical evalua-
tion and an 8-week run-in phase, those meeting study
criteria (compliant with study procedures, at least 5
migraines per month) were randomized to 8 weekly CST
or low-strength static magnet therapy (LSSM) treat-
ments. Study participants were followed for 4 weeks after
the conclusion of therapy. Primary outcome measures
included headache frequency and headache-specific qual-
ity of life (HIT-6). Secondary headache-specific measures
include headache-related disability (MIDAS), headache
intensity, and abortive medication use.
Results
At baseline, participants reported a mean 14 headache
days per month and severe headache-related quality-of-life
impact and disability. Compliance with study procedures
was excellent, with 60 of 69 randomized individuals com-
pleting 8 weeks of therapy. Individuals in both treatment
groups appeared to benefit from the therapy. A significant
difference, favoring CST, was noted by treatment group in
mean headache hours per day 30 days post treatment
(1.89 vs. 2.78, p=0.003). HIT-6 scores decreased signifi-
cantly in both groups, but without a between-group differ-
ence at the last treatment visit. MIDAS scores improved
in the CST, but not the LSSM group at 4 weeks post treat-
ment. Headache intensity was reduced more in the CST
compared with the LSSM group, but the difference was
not statistically significant. Abortive medication use
decreased substantially in both groups during treatment.
Conclusion
Our results show that conducting a randomized clinical
trial of CST for migraine using a standardized protocol is
feasible and that adjunctive CST may reduce headaches in
those with severe migraine. Protocol modifications may
enhance future investigations of CST for migraine.
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